Beam Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.781; its P/E ratio is -13.82; Beam Therapeutics is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-1.14. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 7.41M	$ 316.19M	$ 17.19M	$ 20.12M	$ 24.21M
Gross Profit	$ 7.41M	$ 316.19M	$ 17.19M	$ 20.12M	$ 24.21M
EBIT	$ -110.39M	$ 144.16M	$ -96.09M	$ -82.78M	$ -96.46M
EBITDA	$ -104.95M	$ 149.53M	$ -90.90M	$ -77.96M	$ -91.81M
Net Income Common Stockholders	$ -98.67M	$ 142.80M	$ -96.09M	$ -82.78M	$ -96.46M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.09B	$ 435.89M	$ 1.02B	$ 1.07B	$ 1.06B
Total Assets	$ 1.36B	$ 1.46B	$ 1.29B	$ 1.35B	$ 1.33B
Total Debt	$ 168.12M	$ 172.69M	$ 173.98M	$ 177.13M	$ 178.86M
Net Debt	$ -926.43M	$ -263.21M	$ -841.48M	$ -895.89M	$ -880.61M
Total Liabilities	$ 446.31M	$ 478.38M	$ 511.59M	$ 542.24M	$ 570.85M
Stockholders Equity	$ 913.49M	$ 981.33M	$ 778.94M	$ 811.64M	$ 761.51M
Cash Flow	-
Free Cash Flow	$ -102.19M	$ 131.48M	$ -97.73M	$ -100.85M	$ -115.83M
Operating Cash Flow	$ -99.75M	$ 135.07M	$ -89.78M	$ -84.67M	$ -109.81M
Investing Cash Flow	$ -53.46M	$ 98.10M	$ -10.23M	$ -41.48M	$ 25.45M
Financing Cash Flow	$ 2.90M	$ 33.71M	$ 36.78M	$ 107.54M	$ 98.42M

Currency in USD

Beam Therapeutics Earnings and Revenue History

Income Statement >

Beam Therapeutics Debt to Assets

Balance Sheet >

Beam Therapeutics Cash Flow

Cash Flow >

Beam Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing